Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis

• Main Authors: Sandrine I. Samson (Author), Phillip S. Leventhal (Author), Camille Salamand (Author), Ya Meng (Author), Bruce T. Seet (Author), Victoria Landolfi (Author), David Greenberg (Author), Rosalind Hollingsworth (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: High-dose trivalent, inactivated, split-virus influenza vaccine (IIV3-HD) has been available in the US since 2009 for adults aged ≥ 65 years. To better understand how IIV3-HD provides improved protection against influenza, we systematically reviewed clinical studies comparing immune re...